Skip to main content

Table 1 Baseline characteristics of participants according to metabolic syndrome and obesity profile

From: Strong association between metabolically-abnormal obesity and gallstone disease in adults under 50 years

 

MHNO (n = 1633)

MHO (n = 571)

MANO (n = 292)

MAO (n = 694)

p value

Age, years

48.4 ± 12.5

50 ± 12.2

55.9 ± 10.8

53.3 ± 11.8

<  0.001

Sex,Male (%)

49.6%

71.6%

58.9%

67.4%

<  0.001

Waist circumference (cm)

75.8 ± 6.8

87.5 ± 6.9

82.5 ± 5.8

92.5 ± 7.5

<  0.001

SBP (mmHg)

120 ± 17

125 ± 16

133 ± 18

134 ± 16

<  0.001

DBP (mmHg)

77 ± 10

80 ± 10

83 ± 9

85 ± 10

<  0.001

BMI (kg/m2)

21.8 ± 2.0

26.9 ± 2.0

23.3 ± 1.3

28.3 ± 2.6

<  0.001

FBG (mg/dL)

94 ± 19

95 ± 13

114 ± 40

112 ± 32

<  0.001

HbA1C

5.5 ± 0.8

5.6 ± 0.5

6.2 ± 1.4

6.1 ± 1.2

<  0.001

Bil-T

0.97 ± 0.42

1.00 ± 0.44

0.95 ± 0.39

0.98 ± 0.42

0.207

GOT

25 ± 11

28 ± 13

29 ± 12

31 ± 16

<  0.001

GPT

24 ± 16

32 ± 20

33 ± 20

37 ± 24

<  0.001

r-GT

23 ± 30

29 ± 28

35 ± 32

41 ± 57

<  0.001

ALP

58 ± 18

58 ± 15

65 ± 18

64 ± 19

<  0.001

Total cholesterol (TC)

197 ± 36

203 ± 37

201 ± 44

201 ± 39

0.002

HDL (mg/dL)

54 ± 14

48 ± 10

41 ± 9

40 ± 9

<  0.001

LDL (mg/dL)

122 ± 32

132 ± 33

123 ± 36

126 ± 33

<  0.001

Triglyceride (mg/dL)

88 ± 49

110 ± 75

189 ± 111

188 ± 133

<  0.001

Uric acid

5.4 ± 1.4

6.3 ± 1.4

6.1 ± 1.5

6.7 ± 1.5

<  0.001

BUN

9.6 ± 3.8

10.3 ± 3.5

10.8 ± 4.8

10.8 ± 4.3

<  0.001

Cr

0.78 ± 0.31

0.85 ± 0.21

0.82 ± 0.31

0.87 ± 0.30

<  0.001

HBV

11.5%

12.4%

7.9%

8.5%

0.033

HCV

3.4%

3.0%

6.2%

3.3%

0.084

GB stones

4.4%

6.5%

12.3%

8.9%

<  0.001

  1. ALP alkaline phosphatase, ALT alanine transaminase, AST aspartate transaminase, Bil-T total bilirubin, BMI body mass index, BUN blood urea nitrogen, Cr creatinine, DBP diastolic blood pressure, FBG fasting blood glucose, HbA1c glycated hemoglobin, HBV hepatitis B virus, HCV hepatitis C virus, HDL high-density lipoprotein, LDL low-density lipoprotein, MANO metabolically abnormal but not obese, MAO metabolically abnormal and obese, MHNO metabolically healthy and non-obese, MHO metabolically healthy but obese, r-GT gamma-glutamyl transferase, SBP systolic blood pressure